Career Development Program in the Genetics and Genomics of Lung Diseases (K12)

The summary for the Career Development Program in the Genetics and Genomics of Lung Diseases (K12) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Career Development Program in the Genetics and Genomics of Lung Diseases (K12): The purpose of this funding opportunity announcement (FOA) is to develop multidisciplinary career development programs in genetics and genomics of lung diseases that will equip new investigators with the knowledge and skills [to elucidate their role in the etiology and pathogenesis of such diseases. Through this program, the NHLBI will support the early career development of researchers who are expected to become independent investigators and assume academic leadership roles in this rapidly evolving field. To accomplish this goal, NHLBI invites any eligible institution with the appropriate established infrastructure and expertise in genetics and genomics to submit an application. Programs supported under this RFA should provide comprehensive, multidisciplinary career development opportunities, which includes training in research methodologies, such as genome variation and genome-wide screening, expression profiling technologies as well as informatics and data analysis, in the area of lung diseases. Programs should include a core curriculum, didactics, and a short-term research project for each Scholar.
Federal Grant Title: Career Development Program in the Genetics and Genomics of Lung Diseases (K12)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-07-004
Type of Funding: Grant
CFDA Numbers: 93.838
CFDA Descriptions: Lung Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 01, 2006
Posted Date: Jul 03, 2006
Creation Date: Jul 03, 2006
Archive Date: Dec 31, 2006
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $370,000
Minimum Federal Grant Award:
Expected Number of Awards: 5
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Although foreign institutions are not eligible to apply, foreign collaborators may participate in this program through subcontract(s) with eligible domestic institutions. Applicant institutions must have established research infrastructures and expertise in genetic and genomics and lung diseases and related disciplines. See Section III.3. Other-Specialty Eligibility Criteria.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com